logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Dasatinib CAS 302962-49-8 API Active Pharmaceutical Ingredient

Dasatinib CAS 302962-49-8 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 302962-49-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 302962-49-8 Dasatinib

,

API Active Pharmaceutical Ingredient CAS 302962-49-8

CAS NO::
302962-49-8
Appearance::
Pale-yellow Solid
Molecular Formula::
C22H26ClN7O2S
Molecular Weight::
488.00600
EINECS NO::
801-607-0
MDL NO::
MFCD08704581
CAS NO::
302962-49-8
Appearance::
Pale-yellow Solid
Molecular Formula::
C22H26ClN7O2S
Molecular Weight::
488.00600
EINECS NO::
801-607-0
MDL NO::
MFCD08704581
Dasatinib CAS 302962-49-8 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Dasatinib CAS NO: 302962-49-8

 

 

Synonyms:

Dasatinib Tablets;

N-(2-Chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl}amino)-1,3-thiazole-5-carboxamide;

 

 

Chemical & Physical Properties:

Appearance: Pale-yellow solid

Assay :≥99.0%

Density: 1.408g/cm3

Melting Point: 275-286℃

Index of Refraction: 1.688

Storage Condition: -20℃ Freezer

 

 

Safety Information:

WGK Germany: 3

 

 

Dasatinib, previously known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.